These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 23314612

  • 1. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
    Wang LG, Ni Y, Su BH, Mu XR, Shen HC, Du JJ.
    Int J Oncol; 2013 Mar; 42(3):957-62. PubMed ID: 23314612
    [Abstract] [Full Text] [Related]

  • 2. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC, Li SJ, Zhang F, Pan JY, Wang L, Yang CL, Xi YY, Li de J.
    Oncotarget; 2016 Apr 19; 7(16):21510-26. PubMed ID: 26909600
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
    Sun C, Liu Z, Li S, Yang C, Xue R, Xi Y, Wang L, Wang S, He Q, Huang J, Xie S, Jiang W, Li D.
    Oncotarget; 2015 Sep 22; 6(28):25533-74. PubMed ID: 26325180
    [Abstract] [Full Text] [Related]

  • 4. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E.
    BMC Cancer; 2010 Jun 22; 10():318. PubMed ID: 20569443
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
    Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB.
    Oncogene; 2011 Jun 09; 30(23):2644-58. PubMed ID: 21358675
    [Abstract] [Full Text] [Related]

  • 6. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O, Boeri M, Moro M, Verri C, Mensah M, Conte D, Caleca L, Roz L, Pastorino U, Sozzi G.
    Cell Death Dis; 2014 Dec 11; 5(12):e1564. PubMed ID: 25501825
    [Abstract] [Full Text] [Related]

  • 7. Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features.
    Sun Y, Su B, Zhang P, Xie H, Zheng H, Xu Y, Du Q, Zeng H, Zhou X, Chen C, Gao W.
    Oncol Rep; 2013 Feb 11; 29(2):704-12. PubMed ID: 23228962
    [Abstract] [Full Text] [Related]

  • 8. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y.
    Eur J Cancer; 2014 Sep 11; 50(13):2336-50. PubMed ID: 25001183
    [Abstract] [Full Text] [Related]

  • 9. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH, Zhang CL, Dong FS, Zhang YM.
    J Cell Biochem; 2015 Feb 11; 116(2):268-76. PubMed ID: 25187230
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH.
    Clin Chim Acta; 2010 Jun 03; 411(11-12):846-52. PubMed ID: 20223231
    [Abstract] [Full Text] [Related]

  • 12. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT, Ma ZL, Li YL, Wang YQ, Zhao BT, Wei JL, Qi X, Zhao XT, Jin YX.
    Oncol Rep; 2013 Jul 03; 30(1):492-8. PubMed ID: 23670238
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX.
    BMC Cancer; 2012 Nov 14; 12():519. PubMed ID: 23151088
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D, Wang J, Zhang C, Shan B, Deng X, Li B, Zhou Y, Chen W, Hong J, Gao Y, Chen Z, Duan C.
    Mol Cancer; 2015 Apr 01; 14():73. PubMed ID: 25889562
    [Abstract] [Full Text] [Related]

  • 15. By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.
    Zhang ZY, Fu SL, Xu SQ, Zhou X, Liu XS, Xu YJ, Zhao JP, Wei S.
    Oncotarget; 2015 Jan 30; 6(3):1462-77. PubMed ID: 25596743
    [Abstract] [Full Text] [Related]

  • 16. miR-34b inhibits the migration/invasion and promotes apoptosis of non-small-cell lung cancer cells by YAF2.
    Zhuang XF, Zhao LX, Guo SP, Wei S, Zhai JF, Zhou QH.
    Eur Rev Med Pharmacol Sci; 2019 Mar 30; 23(5):2038-2046. PubMed ID: 30915747
    [Abstract] [Full Text] [Related]

  • 17. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
    Watanabe K, Emoto N, Hamano E, Sunohara M, Kawakami M, Kage H, Kitano K, Nakajima J, Goto A, Fukayama M, Nagase T, Yatomi Y, Ohishi N, Takai D.
    Int J Cancer; 2012 Jun 01; 130(11):2580-90. PubMed ID: 21702040
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
    Xu W, Hang M, Yuan CY, Wu FL, Chen SB, Xue K.
    Int J Clin Exp Pathol; 2015 Jun 01; 8(4):3864-70. PubMed ID: 26097570
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
    Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F, Li D.
    Biochem Biophys Res Commun; 2016 Feb 26; 471(1):82-8. PubMed ID: 26845350
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ.
    J Thorac Oncol; 2011 Apr 26; 6(4):671-8. PubMed ID: 21270667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.